Voyager Therapeutics
VYGR
106 hedge funds and large institutions have $308M invested in Voyager Therapeutics in 2023 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 36 increasing their positions, 21 reducing their positions, and 16 closing their positions.
156% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 16
71% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 21
67% more capital invested
Capital invested by funds: $184M → $308M (+$124M)
40% more call options, than puts
Call options by funds: $1.27M | Put options by funds: $913K
31% more funds holding
Funds holding: 81 → 106 (+25)
6.72% more ownership
Funds ownership: 55.01% → 61.73% (+6.7%)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$17.1M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.29M |
| 3 |
Morgan Stanley
New York
|
+$5.21M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$5.12M |
| 5 |
State Street
Boston,
Massachusetts
|
+$4.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TGI
TRV GP III
Boston,
Massachusetts
|
-$24.6M |
| 2 |
Millennium Management
New York
|
-$11.9M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.64M |
| 4 |
Jane Street
New York
|
-$1.32M |
| 5 |
Goldman Sachs
New York
|
-$949K |
VYGR Hedge Fund Activity: Q2 2023 in Review
106 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q2 2023, worth a combined $308M — up 67% from $184M a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new VYGR positions and 16 closed out — a net gain of 25 holders — while 36 added to existing stakes and 21 trimmed.
The largest buyer was BlackRock, adding an estimated $17.1M. The largest seller was TRV GP III, exiting entirely with an estimated $24.6M sold.
- 106 institutional investors held Voyager Therapeutics (VYGR) as of Q2 2023, up from 81 in Q1 2023.
- Funds reported $308M of Voyager Therapeutics stock for Q2 2023, up 67% quarter-over-quarter.
- 41 funds opened new Voyager Therapeutics positions in Q2 2023 and 16 closed out, a net change of +25 holders.
- The largest Voyager Therapeutics buyer in Q2 2023 was BlackRock, an estimated $17.1M added.
- The largest Voyager Therapeutics seller in Q2 2023 was TRV GP III, an estimated $24.6M sold.
Based on aggregated 13F filings for Q2 2023.